With Mandatory CDISC-Based Submission Looming, CRO A2 Sees Soaring Orders from Japanese Drug Makers

Tomoyoshi Sato (left) and Takashi Misawa Clinical research organizations (CROs) will be inundated with orders related to Clinical Data Interchange Standards Consortium (CDISC) standards in the lead-up to the introduction of CDISC-based electronic regulatory submissions in FY2016, a Tokyo-based CRO...read more